Intraventricular Methotrexate Betters Survival in Medulloblastoma Intraventricular Methotrexate Betters Survival in Medulloblastoma
Intraventricular methotrexate and systemic chemotherapy produced favorable survival outcomes in patients with desmoplastic medulloblastoma and medulloblastoma with extensive nodularity in new study.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news